Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 1226 to 1250 of 2555

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphomaTA577
Endoscopic ablation for an anal fistulaHTG506
Endoscopic ablation for a pilonidal sinusHTG507
Certolizumab pegol for treating moderate to severe plaque psoriasisTA574
Tildrakizumab for treating moderate to severe plaque psoriasisTA575
Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal)TA576
ADXBLADDER for detecting bladder cancerMIB180
Specialist neonatal respiratory care for babies born pretermNG124
Narrow band imaging for Barrett's oesophagusMIB179
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetesTA572
The Debrisoft monofilament debridement pad for use in acute or chronic woundsHTG334
Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancerTA569
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal)TA570
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinibTA571
Kendall DL for ECG monitoring in people having cardiac surgeryMIB177
Radially emitting laser fibre treatment of an anal fistulaHTG505
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal)TA568
Cochlear implants for children and adults with severe to profound deafnessTA566
CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery diseaseMIB174
Prevena incision management system for closed surgical incisionsMIB173
Air pollution: outdoor air quality and healthQS181
People's experience using adult social care servicesQS182
High-intensity focused ultrasound for symptomatic benign thyroid nodulesHTG504
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemiaTA561
Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanomaTA562

Results per page

  1. 10
  2. 25
  3. 50
  4. All